CpG and non-CpG Presenilin1 methylation pattern in course of neurodevelopment and neurodegeneration is associated with gene expression in human and murine brain

References

• Hass MR, Sato C, Kopan R, et al. Presenilin: RIP and beyond. Semin Cell Dev Biol. 2009;20:201–210.
   PubMed Web of Science ®Google Scholar
• Edbauer D, Winkler E, Regula JT, et al. Reconstitution of gamma-secretase activity. Nat Cell Biol. 2003;5:486–488.
   PubMed Web of Science ®Google Scholar
• Iwatsubo T. The gamma-secretase complex: machinery for intramembrane proteolysis. Curr Opin Neurobiol. 2004;14:379–383.
   PubMed Web of Science ®Google Scholar
• Lleó A. Activity of gamma-secretase on substrates other than APP. Curr Top Med Chem. 2008;8:9–16.
   PubMed Web of Science ®Google Scholar
• Lathia JD, Mattson MP, Cheng A. Notch: from neural development to neurological disorders. J Neurochem. 2008;107:1471–1481.
   PubMed Web of Science ®Google Scholar
• Jurisch-Yaksi N, Sannerud R, Annaert W. A fast growing spectrum of biological functions of γ-secretase in development and disease. Biochim Biophys Acta. 2013;1828:2815–2827.
   PubMed Web of Science ®Google Scholar
• Selkoe D, Kopan R. Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration. Annu Rev Neurosci. 2003;26:565–597.
   PubMed Web of Science ®Google Scholar
• Bothwell M, Giniger E. Alzheimer’s disease: neurodevelopment converges with neurodegeneration. Cell. 2000 Aug 4;102(3):271–273.
   PubMed Web of Science ®Google Scholar
• Lardenoije R, Iatrou A, Kenis G, et al. The epigenetics of aging and neurodegeneration. Prog Neurobiol. 2015;131:21–64.
   PubMed Web of Science ®Google Scholar
• Sanchez-Mut JV, Gräff J. Epigenetic alterations in Alzheimer’s disease. Front Behav Neurosci. 2015;9:347.
   PubMed Web of Science ®Google Scholar
• Migliore L, Coppedè F. Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases. Mutat Res. 2009;667:82–97.
   PubMed Web of Science ®Google Scholar
• Fuso A, Scarpa S. One-carbon metabolism and Alzheimer’s disease: is it all a methylation matter? Neurobiol Aging. 2011;32:1192–1195.
   PubMed Web of Science ®Google Scholar
• Nicolia V, Lucarelli M, Fuso A. Environment, epigenetics and neurodegeneration: focus on nutrition in Alzheimer’s disease. Exp Gerontol. 2015;68:8–12.
   PubMed Web of Science ®Google Scholar
• Mastroeni D, Grover A, Delvaux E, et al. Epigenetic mechanisms in Alzheimer’s disease. Neurobiol Aging. 2011;32:1161–1180.
   PubMed Web of Science ®Google Scholar
• Eden S, Cedar H. Role of DNA methylation in the regulation of transcription. Curr Opin Genet Dev. 1994;4:255–259.
   PubMed Web of Science ®Google Scholar
• Fuso A, Seminara L, Cavallaro RA, et al. S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production. Mol Cell Neurosci. 2005;28:195–204.
   PubMed Web of Science ®Google Scholar
• Fuso A, Nicolia V, Pasqualato A, et al. Changes in Presenilin 1 gene methylation pattern in diet-induced B vitamin deficiency. Neurobiol Aging. 2011;32:187–199.
   PubMed Web of Science ®Google Scholar
• Fuso A, Nicolia V, Cavallaro RA, et al. DNA methylase and demethylase activities are modulated by one-carbon metabolism in Alzheimer’s disease models. J Nutr Biochem. 2011;22:242–251.
   PubMed Web of Science ®Google Scholar
• Fuso A, Nicolia V, Ricceri L, et al. S-adenosylmethionine reduces the progress of the Alzheimer-like features induced by B-vitamin deficiency in mice. Neurobiol Aging. 2012;33:1482.e1–16.
   PubMed Web of Science ®Google Scholar
• Fuso A, Cavallaro RA, Nicolia V, et al. PSEN1 promoter demethylation in hyperhomocysteinemic TgCRND8 mice is the culprit, not the consequence. Curr Alzheimer Res. 2012;9:527–535.
   PubMed Web of Science ®Google Scholar
• Schrötter A, Pfeiffer K, El Magraoui F, et al. The amyloid precursor protein (APP) family members are key players in S-adenosylmethionine formation by MAT2A and modify BACE1 and PSEN1 gene expression-relevance for Alzheimer’s disease. Mol Cell Proteomics. 2012;11:1274–1288.
   PubMed Web of Science ®Google Scholar
• Li W, Liu H, Yu M, et al. Folic acid administration inhibits amyloid β-peptide accumulation in APP/PS1 transgenic mice. J Nutr Biochem. 2015;26:883–891.
   PubMed Web of Science ®Google Scholar
• Wang SC, Oelze B, Schumacher A. Age-specific epigenetic drift in late-onset Alzheimer’s disease. PLoS One. 2008;3:e2698.
   PubMed Web of Science ®Google Scholar
• Barrachina M, Ferrer I. DNA methylation of Alzheimer disease and tauopathy-related genes in postmortem brain. J Neuropathol Exp Neurol. 2009;68:880–891.
   PubMed Web of Science ®Google Scholar
• Tannorella P, Stoccoro A, Tognoni G, et al. Methylation analysis of multiple genes in blood DNA of Alzheimer’s disease and healthy individuals. Neurosci Lett. 2015;600:143–147.
   PubMed Web of Science ®Google Scholar
• Carboni L, Lattanzio F, Candeletti S, et al. Peripheral leukocyte expression of the potential biomarker proteins Bdnf, Sirt1, and Psen1 is not regulated by promoter methylation in Alzheimer’s disease patients. Neurosci Lett. 2015;605:44–48.
   PubMed Web of Science ®Google Scholar
• Fuso A, Ferraguti G, Grandoni F, et al. Early demethylation of non-CpG, CpC-rich, elements in the myogenin 5ʹ-flanking region: a priming effect on the spreading of active demethylation. Cell Cycle. 2010;9:3965–3976.
   PubMed Web of Science ®Google Scholar
• Fuso A, Ferraguti G, Scarpa S, et al. Disclosing bias in bisulfite assay: methPrimers underestimate high DNA methylation. PLoS One. 2015;10:e0118318.
   PubMed Web of Science ®Google Scholar
• Fuso A, Scarpa S, Grandoni F, et al. A reassessment of semiquantitative analytical procedures for DNA methylation: comparison of bisulfite- and HpaII polymerase-chain-reaction-based methods. Anal Biochem. 2006;350:24–31.
   PubMed Web of Science ®Google Scholar
• Patil V, Ward RL, Hesson LB. The evidence for functional non-CpG methylation in mammalian cells. Epigenetics. 2014;9:823–828.
   PubMed Web of Science ®Google Scholar
• Ziller MJ, Müller F, Liao J, et al. Genomic distribution and inter-sample variation of non-CpG methylation across human cell types. PLoS Genet. 2011;7:e1002389.
   PubMed Web of Science ®Google Scholar
• Nishino K, Hattori N, Sato S, et al. Non-CpG methylation occurs in the regulatory region of the Sry gene. J Reprod Dev. 2011;57:586–593.
   PubMed Web of Science ®Google Scholar
• Guo JU, Su Y, Shin JH, et al. Distribution, recognition and regulation of non-CpG methylation in the adult mammalian brain. Nat Neurosci. 2014;17:215–222.
   PubMed Web of Science ®Google Scholar
• Kozlenkov A, Roussos P, Timashpolsky A, et al. Differences in DNA methylation between human neuronal and glial cells are concentrated in enhancers and non-CpG sites. Nucleic Acids Res. 2014;42:109–127.
   PubMed Web of Science ®Google Scholar
• Blanch M, Mosquera JL, Ansoleaga B, et al. Altered mitochondrial DNA methylation pattern in Alzheimer disease-related pathology and in Parkinson disease. Am J Pathol. 2016;186:385–397.
   PubMed Web of Science ®Google Scholar
• Lin HC, Hsieh HM, Chen YH, et al. S-Adenosylhomocysteine increases beta-amyloid formation in BV-2 microglial cells by increased expressions of beta-amyloid precursor protein and presenilin 1 and by hypomethylation of these gene promoters. Neurotoxicology. 2009;30:622–627.
   PubMed Web of Science ®Google Scholar
• Kumar A, Thakur MK. Epigenetic regulation of presenilin 1 and 2 in the cerebral cortex of mice during development. Dev Neurobiol. 2015;75:1165–1173.
   PubMed Web of Science ®Google Scholar
• Niu H, Álvarez-Álvarez I, Guillén-Grima F, et al. Prevalence and incidence of Alzheimer’s disease in Europe: A meta-analysis. Neurologia. 2016;32:pii:S0213-4853(16)30003–2.
   PubMed Web of Science ®Google Scholar
• Fuso A, Iyer AM, van Scheppingen J, et al. Promoter-specific hypomethylation correlates with IL-1β overexpression in Tuberous Sclerosis Complex (TSC). J Mol Neurosci. 2016;59:464–470.
   PubMed Web of Science ®Google Scholar
• Nicolia V, Cavallaro RA, López-González I, et al. DNA methylation profiles of selected pro-inflammatory cytokines in Alzheimer disease. J Neuropathol Exp Neurol. 2017;76:27–31.
   PubMed Web of Science ®Google Scholar
• Lister R, Mukamel EA, Nery JR, et al. Global epigenomic reconfiguration during mammalian brain development. Science. 2013;341:1237905.
   PubMed Web of Science ®Google Scholar
• Fuso A, Cavallaro RA, Zampelli A, et al. gamma-Secretase is differentially modulated by alterations of homocysteine cycle in neuroblastoma and glioblastoma cells. J Alzheimers Dis. 2007;11:275–290.
   PubMed Web of Science ®Google Scholar
• Yu L, Chibnik LB, Yang J, et al. Methylation profiles in peripheral blood CD4+ lymphocytes versus brain: the relation to Alzheimer’s disease pathology. Alzheimers Dement. 2016;12:942–951.
   PubMed Web of Science ®Google Scholar
• Huo Z, Zhu Y, Yu L, et al. DNA methylation variability in Alzheimer’s disease. Neurobiol Aging. 2018;76:35–44.
   PubMed Web of Science ®Google Scholar
• Lunnon K, Smith R, Hannon E, et al. Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer’s disease. Nat Neurosci. 2014;17:1164–1170.
   PubMed Web of Science ®Google Scholar
• De Jager PL, Srivastava G, Lunnon K, et al. Alzheimer’s disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat Neurosci. 2014;17:1156–1163.
   PubMed Web of Science ®Google Scholar
• Grossi E, Stoccoro A, Tannorella P, et al. Artificial neural networks link one-carbon metabolism to gene-promoter methylation in Alzheimer’s disease. J Alzheimers Dis. 2016;53(4):1517–1522.
   PubMed Web of Science ®Google Scholar
• BLUEPRINT consortium. Quantitative comparison of DNA methylation assays for biomarker development and clinical applications. Nat Biotechnol. 2016;34:726–737.
   PubMed Web of Science ®Google Scholar
• Smith AR, Smith RG, Pishva E, et al. Parallel profiling of DNA methylation and hydroxymethylation highlights neuropathology-associated epigenetic variation in Alzheimer’s disease. Clin Epigenetics. 2019;11(1):52.
   PubMedGoogle Scholar
• Chishti MA, Yang DS, Janus C, et al. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem. 2001;276:21562–21570.
   PubMed Web of Science ®Google Scholar
• Canterini S, Bosco A, Carletti V, et al. Subcellular TSC22D4 localization in cerebellum granule neurons of the mouse depends on development and differentiation. Cerebellum. 2012;11:28–40.
   PubMed Web of Science ®Google Scholar
• Palladino G, Nicolia V, Kovacs GG, et al. Sexually dimorphic expression of reelin in the brain of a mouse model of Alzheimer disease. J Mol Neurosci. 2017;61:359–367.
   PubMed Web of Science ®Google Scholar
• López-González I, Schlüter A, Aso E, et al. Neuroinflammatory signals in Alzheimer disease and APP/PS1 transgenic mice: correlations with plaques, tangles, and oligomeric species. J Neuropathol Exp Neurol. 2015;74:319–344.
   PubMed Web of Science ®Google Scholar
• Fuso A, Nicolia V, Cavallaro RA, et al. B-vitamin deprivation induces hyperhomocysteinemia and brain S-adenosylhomocysteine, depletes brain S-adenosylmethionine, and enhances PS1 and BACE expression and amyloid-beta deposition in mice. Mol Cell Neurosci. 2008;37:731–746.
   PubMed Web of Science ®Google Scholar
• Piscopo P, Canterini S, Carletti V, et al. Sex effect on presenilins expression in post-natal rat brain. Adv Biosci Biotechnol. 2013;4:1086–1094.
   Google Scholar